Antibiotic News and Research

RSS
Scientists receive €85 million international drive to develop new and effective drugs

Scientists receive €85 million international drive to develop new and effective drugs

Pitt’s CMI funds 6 research groups for Early Stage Medical Technology Research and Development

Pitt’s CMI funds 6 research groups for Early Stage Medical Technology Research and Development

Drug used for treating breast cancer also kills fungal disease

Drug used for treating breast cancer also kills fungal disease

Research roundup: Value-based insurance; telemedicine in nursing homes; advance care planning

Research roundup: Value-based insurance; telemedicine in nursing homes; advance care planning

Novel combined therapy for treatment of septic patients in ICU

Novel combined therapy for treatment of septic patients in ICU

Chinese scientists confirm world’s first case of human infection with new avian influenza virus

Chinese scientists confirm world’s first case of human infection with new avian influenza virus

Scientists develop fully automated system to identify sepsis in infants within hours

Scientists develop fully automated system to identify sepsis in infants within hours

Addressing antibiotic resistance: an interview with Professor Otto Cars, Uppsala University, Sweden

Addressing antibiotic resistance: an interview with Professor Otto Cars, Uppsala University, Sweden

Researchers develop antibiotic "smart bomb" that can identify specific strains of bacteria

Researchers develop antibiotic "smart bomb" that can identify specific strains of bacteria

Researchers identify chemical substance to treat bacterial infections

Researchers identify chemical substance to treat bacterial infections

NPS MedicineWise urges health professionals to take the pledge to fight antibiotic resistance

NPS MedicineWise urges health professionals to take the pledge to fight antibiotic resistance

Scientists produce new version of old antibiotic that is active against difficult-to-treat tuberculosis

Scientists produce new version of old antibiotic that is active against difficult-to-treat tuberculosis

Researchers discover unusually large bacteriophage that infects anthrax bacterium

Researchers discover unusually large bacteriophage that infects anthrax bacterium

FOB Synthesis enters into license agreement with AstraZeneca to treat drug-resistant bacterial infections

FOB Synthesis enters into license agreement with AstraZeneca to treat drug-resistant bacterial infections

New versions of old antibiotic offers strategy for overcoming drug resistance

New versions of old antibiotic offers strategy for overcoming drug resistance

Scientists start clinical trial of EDP-788 oral antibiotic to treat MRSA infections

Scientists start clinical trial of EDP-788 oral antibiotic to treat MRSA infections

Study finds new class of semisynthetic anti-tuberculosis agents that overcome native drug efflux

Study finds new class of semisynthetic anti-tuberculosis agents that overcome native drug efflux

NextSource BioTechnology announces product re-launch, market availability of Lomustine in U.S.

NextSource BioTechnology announces product re-launch, market availability of Lomustine in U.S.

ITAC assists in international distribution of NanoLogix products by Nasaem Al-Jazira

ITAC assists in international distribution of NanoLogix products by Nasaem Al-Jazira

E.R. expert warns public about 5 things doctor may do wrong when treating for flu

E.R. expert warns public about 5 things doctor may do wrong when treating for flu

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.